(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 4.99% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.2%.
Treace Medical Concepts's revenue in 2026 is $205,307,000.On average, 7 Wall Street analysts forecast TMCI's revenue for 2026 to be $13,763,912,585, with the lowest TMCI revenue forecast at $13,154,538,833, and the highest TMCI revenue forecast at $14,203,546,157. On average, 7 Wall Street analysts forecast TMCI's revenue for 2027 to be $14,702,361,171, with the lowest TMCI revenue forecast at $13,919,345,165, and the highest TMCI revenue forecast at $15,508,139,270.
In 2028, TMCI is forecast to generate $15,686,984,288 in revenue, with the lowest revenue forecast at $14,658,788,021 and the highest revenue forecast at $16,791,921,326.